News & Analysis on Clinical Trial Services & Contract Research And Development
US drug giant Pfizer, has signed a license agreement to market a specific class of non-hormonal drugs to treat the hot flushes associated with menopause. The new drug,currently in development, is set to become the first of its kind on the market and...
Charles River Laboratories third quarterly performance in the third quarter of 2004 reflected the current market climate for products and services that support the drug discovery and development process, with notable increases in operating income and...
A recent exhibitions on anti-infectives means that antibiotics and other drugs for other infectious diseases feature strongly in DrugResearcher's periodic round-up of new compounds entering the clinic.